Impact of SA 14-14-2 vaccination on the occurrence of Japanese encephalitis in India
Japanese encephalitis virus is the major cause of encephalitis in India. To control the increasing incidence and fatal outbreaks, SA 14-14-2 vaccine was introduced initially in 104 endemic districts in phased manner from 2006 to 2011. As there is no data available before 2008 on the number of Japane...
Main Authors: | Mayilsamy Muniaraj, Veeramanoharan Rajamannar |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2019-04-01
|
Series: | Human Vaccines & Immunotherapeutics |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/21645515.2018.1564435 |
Similar Items
-
Use of the live attenuated Japanese Encephalitis vaccine SA 14–14–2 in children: A review of safety and tolerability studies
by: Amy Sarah Ginsburg, et al.
Published: (2017-10-01) -
Antibody persistence and immune memory response following primary vaccination and boosting with live attenuated SA 14-14-2 Japanese encephalitis vaccine (CD-JEV) in Bangladesh: A phase 4 open-label clinical trial
by: K. Zaman, et al.
Published: (2022-04-01) -
Effectiveness of the SA 14-14-2 Live-Attenuated Japanese Encephalitis Vaccine in Myanmar
by: Mya Myat Ngwe Tun, et al.
Published: (2021-05-01) -
Envelope Protein Mutations L107F and E138K Are Important for Neurovirulence Attenuation for Japanese Encephalitis Virus SA14-14-2 Strain
by: Jian Yang, et al.
Published: (2017-01-01) -
Past, Present, and Future of Japanese Encephalitis
by: Susan L. Hills, et al.
Published: (2009-08-01)